Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity.
Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity.
复制标题
循环 25-羟基维生素 D、鼻咽微生物群和细支气管炎严重程度。
DOI:
10.1111/pai.12977
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
CamargoJr,CarlosA
中科院分区:
文献类型:
--
作者:
Toivonen,Laura;Hasegawa,Kohei;Ajami,NadimJ;Celedón,JuanC;Mansbach,JonathanM;Petrosino,JosephF;CamargoJr,CarlosA
Bronchiolitis is the leading cause of hospitalization in US infants, among which approximately 15% require intensive care. 1 Emerging evidence suggest a complex interplay between viral infection, airway microbiota, and host immune response in the pathobiology of bronchiolitis. 2 Vitamin D compounds have pleiotropic regulatory roles on both innate and adaptive immune responses. 3 Low levels of 25-hydroxyvitamin D (25OHD), the major circulating form of vitamin D, have been found to be associated with higher risk and severity of acute respiratory infections (ARIs) in children. 4 Recent studies also have reported an association of maternal5 and cord blood6 vitamin D levels with infant gut microbiota. Yet, there have been no studies investigating interactions between circulating 25OHD and airway microbiota on ARI severity in children. We have previously reported that infants with Haemophilus-dominant nasopharyngeal microbiota profile are at highest risk for intensive care use during bronchiolitis hospitalization. 1 In the current analysis, we examined the same